Refractory Pancreatic Adenocarcinoma
3 clinical trials · Condition
◉ Watch Refractory Pancreatic Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure (NCT07175389) | West China Hospital | 2026-09-01 |
| TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma (NCT07189195) | University of California, Davis | 2025-11-07 |
| SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer (NCT04050085) | University of California, Davis | 2019-08-15 |
Track Refractory Pancreatic Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.